Mavroudis, I.; Chowdhury, R.; Petridis, F.; Karantali, E.; Chatzikonstantinou, S.; Balmus, I.M.; Luca, I.S.; Ciobica, A.; Kazis, D.
YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease. Medicina 2022, 58, 60.
https://doi.org/10.3390/medicina58010060
AMA Style
Mavroudis I, Chowdhury R, Petridis F, Karantali E, Chatzikonstantinou S, Balmus IM, Luca IS, Ciobica A, Kazis D.
YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease. Medicina. 2022; 58(1):60.
https://doi.org/10.3390/medicina58010060
Chicago/Turabian Style
Mavroudis, Ioannis, Rumana Chowdhury, Foivos Petridis, Eleni Karantali, Symela Chatzikonstantinou, Ioana Miruna Balmus, Iuliana Simona Luca, Alin Ciobica, and Dimitrios Kazis.
2022. "YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease" Medicina 58, no. 1: 60.
https://doi.org/10.3390/medicina58010060
APA Style
Mavroudis, I., Chowdhury, R., Petridis, F., Karantali, E., Chatzikonstantinou, S., Balmus, I. M., Luca, I. S., Ciobica, A., & Kazis, D.
(2022). YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer’s Disease. Medicina, 58(1), 60.
https://doi.org/10.3390/medicina58010060